Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
G-Vest Capital is a leading South Korean venture capital firm exclusively focused on the life sciences and bio-healthcare sectors. Founded in 2018 and headquartered in Seoul, the firm manages multiple specialized investment funds targeting early-to-late-stage startups in biotechnology, medical technology, and digital health. G-Vest Capital is recognized for its strategic role in the Korean biotech ecosystem, providing capital and industry expertise to companies developing innovative therapeutics and diagnostic tools. The firm's investment portfolio includes prominent Korean biopharmaceutical companies such as Bridge Biotherapeutics, GI Innovation, and ImmuneOncia. Additionally, G-Vest Capital frequently collaborates on government-backed initiatives, including the management of the K-Bio Vaccine Fund to support pharmaceutical innovation and commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on G-Vest Capital.